Changli Wang
Tianjin Medical University Cancer Institute and Hospital
3
3
0
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (3)
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Charles Simone, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Carri Glide-Hurst, PhD, DABR, FAAPM
University of Wisconsin, Madison
Shared therapeutic areas:
Esra Gümüştepe, M.D
Ankara University
Shared therapeutic areas:
Michael Farris, MD
Wake Forest University Health Sciences
Shared therapeutic areas:
James Isbell, MD
Memorial Sloan Kettering Cancer Center
Shared therapeutic areas:
Michael Farris, MD
Wake Forest Baptist Comprehensive Cancer Center
Shared therapeutic areas:
Roberto Ferrara
Fondazione IRCCS ISTITUTO NAZIONALE TUMORI
Shared therapeutic areas:
Alexander Chi, MD
Capital Medical University
Shared therapeutic areas:
Kathleen Castro, R.N.
National Cancer Institute (NCI)
Shared therapeutic areas:
Julien MAZIERES, MD, phD
University Hospital, Toulouse
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (3)
Showing 3 of 3 trials
AK112 Neoadjuvant/Adjuvant Treatment for Resectable NSCLC
Erlotinib Versus Vinorelbine/Cisplatin as Adjuvant Treatment in Stage IIIA NSCLC Patients With EGFR Mutations
Erlotinib in Post Radical Operation NSCLC Patients With EGFR Mutation
All 3 trials loaded